MegaPro Biomedical submits FDA application for Phase III MPB-1523 trial
MegaPro Biomedical Co Ltd has submitted an application to the FDA to conduct a Phase III trial on MPB-1523.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.